Juq-470: ((link))
The sponsor is collaborating with a diagnostics partner to co‑develop a that will be submitted alongside a future New Drug Application (NDA) if Phase II/III data prove favorable.
The sponsor is collaborating with a diagnostics partner to co‑develop a that will be submitted alongside a future New Drug Application (NDA) if Phase II/III data prove favorable.
